Evolent Health A Aktie
3,36
EUR
+0,02
EUR
+0,60
%
3,95
USD
+0,03
USD
+0,64
%
Werbung
Evolent Health A Aktie Analyse
| 01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
| 13.07.16 | Evolent Health A Outperform | FBR Capital | |
| 29.03.16 | Evolent Health A Outperform | FBR Capital | |
| 06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung